Chemoinformaics analysis of 2,4-Pentadienenitrile
| Molecular Weight | 79.102 | nRot | 1 |
| Heavy Atom Molecular Weight | 74.062 | nRig | 3 |
| Exact Molecular Weight | 79.0422 | nRing | 0 |
| Solubility: LogS | -1.251 | nHRing | 0 |
| Solubility: LogP | 0.936 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 11 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 5 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 12.784 |
| nHD | 0 | BPOL | 5.58603 |
| QED | 0.343 |
| Synth | 3.812 |
| Natural Product Likeliness | 1.822 |
| NR-PPAR-gamma | 0.289 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.005 |
| CACO-2 | -4.295 |
| MDCK | 0.000026 |
| BBB | 0.749 |
| PPB | 0.376745 |
| VDSS | 0.506 |
| FU | 0.521624 |
| CYP1A2-inh | 0.806 |
| CYP1A2-sub | 0.146 |
| CYP2c19-inh | 0.277 |
| CYP2c19-sub | 0.557 |
| CYP2c9-inh | 0.117 |
| CYP2c9-sub | 0.942 |
| CYP2d6-inh | 0.37 |
| CYP2d6-sub | 0.872 |
| CYP3a4-inh | 0.066 |
| CYP3a4-sub | 0.217 |
| CL | 6.65 |
| T12 | 0.801 |
| hERG | 0.006 |
| Ames | 0.739 |
| ROA | 0.936 |
| SkinSen | 0.882 |
| Carcinogencity | 0.871 |
| EI | 0.996 |
| Respiratory | 0.976 |
| NR-Aromatase | 0.175 |
| Antiviral | No |
| Prediction | 0.909361 |